Repligen Cp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | QGEN | ROIV | ||
| Company | Repligen Cp | Qiagen N.V. | Roivant Sciences Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 170.10 | 43.39 | 11.48 | ||
| High | 172.00 | 43.51 | 11.50 | ||
| Low | 166.43 | 42.92 | 11.28 | ||
| Last | 167.05 | 42.98 | 11.39 | ||
| Change | +0.74 | +0.30 | +0.15 | ||
| % Change | +0.44% | +0.70% | +1.33% | ||
| Volume | 454,900 | 1,317,900 | 3,693,300 | ||
| 20-Day Average Volume | 531,720 | 1,159,945 | 4,475,540 | ||
| Previous Close | 166.31 | 42.68 | 11.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 166.81 | 41.21 | 10.97 | ||
| 20-Day Raw Stochastic | 50.12% | 88.17% | 73.29% | ||
| 20-Day Relative Strength | 44.47% | 55.98% | 57.06% | ||
| Weighted Alpha | -2.63 | -4.21 | +27.58 | ||
| Today's Opinion | 40% Sell | 16% Buy | 100% Buy | ||
| Previous Opinion | 56% Sell | 16% Buy | 96% Buy | ||
| Last Month's Opinion | 24% Buy | 8% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 04/26/24 | +3.19% since 04/26/24 | +3.26% since 04/26/24 | ||
| Low | 151.82 on 05/01/24 | 41.49 on 04/30/24 | 10.89 on 04/30/24 | ||
| High | 172.00 on 05/03/24 | 43.51 on 05/03/24 | 11.50 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -5.79% since 04/03/24 | +2.55% since 04/03/24 | -1.04% since 04/03/24 | ||
| Low | 151.82 on 05/01/24 | 39.03 on 04/18/24 | 10.27 on 04/19/24 | ||
| High | 182.21 on 04/09/24 | 43.51 on 05/03/24 | 11.80 on 04/08/24 | ||
| 3-Month | |||||
| %Chg | -14.84% since 02/02/24 | -1.22% since 02/02/24 | +15.17% since 02/02/24 | ||
| Low | 151.82 on 05/01/24 | 39.03 on 04/18/24 | 9.69 on 02/05/24 | ||
| High | 211.13 on 02/16/24 | 45.38 on 02/06/24 | 12.00 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | +11.10% since 11/03/23 | +9.64% since 11/03/23 | +22.74% since 11/03/23 | ||
| Low | 142.68 on 11/10/23 | 37.51 on 11/10/23 | 8.47 on 11/13/23 | ||
| High | 211.13 on 02/16/24 | 45.88 on 01/09/24 | 12.00 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,334,084 | 9,808,165 | 9,178,586 | ||
| Shares Outstanding, K | 55,876 | 228,203 | 805,846 | ||
| Annual Sales | 638,760,000 | 1,965,310,000 | 61,280,000 | ||
| Annual Net Income | 41,580,000 | 341,300,000 | -1,009,030,000 | ||
| Last Quarter Sales | 155,740,000 | 509,160,000 | 37,140,000 | ||
| Last Quarter Net Income | -25,490,000 | 97,660,000 | 5,096,180,000 | ||
| 60-Month Beta | 1.03 | 0.42 | 1.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.28 on 05/01/24 | 0.46 on 04/29/24 | -0.21 on 02/13/24 | ||
| Latest Earnings Date | 05/01/24 | 04/29/24 | 06/26/24 | ||
| Most Recent Dividend | N/A | 0.027 on 12/27/02 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 121.39 | 20.81 | 0.00 | ||